BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Titan Spine Receives CE Mark Certification for Endoskeleton(R) Lumbar Interbody Fusion Devices


4/5/2011 7:03:19 AM

MEQUON, Wis.--(BUSINESS WIRE)-- Titan Spine, a medical device surface technology company focused on the development of innovative spinal interbody fusion implants, announced today that it has received CE Mark Certification to commercially release its line of Endoskeleton® lumbar interbody fusion devices in Europe. The implants, which consist of the Endoskeleton® TA (ALIF), Endoskeleton® TT (TLIF), and Endoskeleton® TO (PLIF and Oblique), feature a unique roughened titanium surface topography that is designed to promote rapid bony integration and subsequent fusion. The company plans to immediately begin conducting surgical cases within the European Union.

“Obtaining the CE Mark on our lumbar systems is a significant milestone for our company,” commented Kevin Gemas, President of Titan Spine. “This will allow us to aggressively market our titanium surface technology in Europe, where the $160 Million-dollar interbody marketplace is trending towards titanium at a rate that even exceeds that of the United States. In addition, we plan to obtain CE Mark Certification on our cervical product line in the near future to further increase our addressable market in Europe.”

Scott Van Ells, Senior Quality Assurance & Regulatory Affairs Director for Titan Spine, spearheaded the project. “The timeframe in which we were able to accomplish the CE Mark accreditation speaks volumes to our Quality Management System and the efforts of the entire organization,” he stated. “The flexibility in allowing for a dynamic exchange of ideas to ensure that all domestic regulatory requirements are maintained while including additional requirements for the European Union was vital to the success of this project.”

About the Company – Titan Spine, LLC is a privately-owned medical implant surface technology company in Mequon, Wisconsin that is focused on the design and manufacturing of proprietary interbody fusion devices for the spine. Founded in 2005, the company is committed to advancing the science of titanium surface engineering to enhance the treatment of various pathologies of the spine that require fusion.

Contact:

Titan Spine Andrew Shepherd, 866-822-7800 www.titanspine.com

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES